Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to -$69000.0.

  • Treace Medical Concepts' Asset Writedowns and Impairment fell 13965.52% to -$69000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 6059.94%. This contributed to the annual value of $2.9 million for FY2024, which is 57903.23% up from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' Asset Writedowns and Impairment is -$69000.0, which was down 13965.52% from $81000.0 recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' Asset Writedowns and Impairment peaked at $2.0 million during Q2 2024, and registered a low of -$227000.0 during Q2 2022.
  • Its 5-year average for Asset Writedowns and Impairment is $246588.2, with a median of $40000.0 in 2023.
  • In the last 5 years, Treace Medical Concepts' Asset Writedowns and Impairment tumbled by 20547.95% in 2021 and then skyrocketed by 1730000.0% in 2024.
  • Treace Medical Concepts' Asset Writedowns and Impairment (Quarter) stood at -$35000.0 in 2021, then skyrocketed by 1862.86% to $617000.0 in 2022, then tumbled by 42.46% to $355000.0 in 2023, then surged by 59.44% to $566000.0 in 2024, then plummeted by 112.19% to -$69000.0 in 2025.
  • Its Asset Writedowns and Impairment was -$69000.0 in Q3 2025, compared to $81000.0 in Q2 2025 and $500000.0 in Q1 2025.